📌 Key Takeaways
- Topic: Copper Clad Laminate Filler: Silica Types, Dielectric Properties and Selection
- Keywords: silica for HPLC
- Published: 2026-11-20 01:02:14
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Aerosil R972: Specifications, Hydrophobic Properties and Equivalent Grades
- Silica for Adhesives: Thickening, Thixotropy and Reinforcement Explained
- What Is Silane Treated Silica? How Silane Modification Improves Dispersion and Performance
- By connecting different functional groups, smaller or larger changes can be observed in the surface charge (zeta potential values) and hydrophilicity/hydrophobicity of SNPs [ 14, 18 ]. Such functional groups can be, for instance, -NH 2, -PO 3, -SH, -COOH, and -CH 3 [ 14, 18 ]. By functionalizing the internal surface (pores), the drug loading and the stability of the molecules can be raised, the release kinetics can be influenced, and even controlled release can be created [ 2, 18, 27 ]. By functionalizing the outer surface, the stability and biocompatibility of the particles can be improved [ 2, 27 ]. The outer surface also affects the interactions with the cell membrane, cellular uptake, and penetration [ 2, 12, 18, 27, 28 ], and lets the creation of cell-specific targeted therapy [ 2, 27 ]. The hydrophilic/neutral surface favors permeability through the mucus hurdle, while the hydrophobic/cationic surface promotes penetration through epithelial cells [ 12, 18 ]. Cationic nanoparticles have a higher degree of internalization than anionic particles [ 18, 28 ]. Positively charged functional groups (-NH 2 ) can establish electrostatic interactions with the negatively charged cell membrane, leading to raised endocytosis compared to negatively charged groups (-SH) [ 18, 28 ]. SNPs also have permeation-enhancing properties as they can temporarily open epithelial tight junctions owing to their size and surface, thereby increasing the drug absorption [ 13, 14 ]. SNPs smaller than 200 nm with a negative surface charge have this property [ 13 ], while particles with a positive or neutral surface do not show similar effects [ 13 ].
- Silica Carrier for Pesticides: Absorption Capacity, Flowability and Grade Selection
- Silicon Dioxide Chemical Properties: Reactivity, Stability and Key Reactions
- The authors declare no conflicts of interest.
Is Silica in Cosmetics Safe? Ingredient Safety and Regulatory Status
What is silica (SiO₂)?
fumed silica alternative 81. Yusuf A., Almotairy A.R.Z., Henidi H., Alshehri O.Y., Aldughaim M.S. Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles' Physicochemical Properties on Responses in Biological Systems. Polymers. 2023;15:1596. doi: 10.3390/polym15071596. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
What is the difference between fumed silica and precipitated silica?
is silica soluble in water
What drives silica raw material prices?
silicon dioxide common name Ho et al. employed the Multiple-Path Particle Dosimetry (MPPD) model for aerosolization and determination of lung deposition of silver nanoparticles, which method may be broadened to other materials like mesoporous silica nanoparticles [ 87 ]. It suggests particle size (mean 18 nm), density, and generation approach as principal elements that determine aerosolization efficiency and inhaled dose. Simulations of airflow, diffusion, sedimentation, and impact through airway generations yield comparable alveolar deposition fractions for particles less than 100 nm in humans and rats. With the addition of species-specific parameters, such as respiratory rate, lung surface region, tidal volume, and finished with possible lobar- and airway-level analysis, the MPPD model makes realistic regional retention predictions. Given that mesoporous silica nanoparticles are of similar size and physicochemical properties, the same methodology can estimate their aerosolization and lung deposition. In summary, the MPPD model is a handy tool in the assessment of inhalation danger and in guiding the formulation of safer nanomaterials [ 87 ]. In another study, Ali et al. applied the MPPD model to simulate aerosolization and lung deposition of mesoporous silica nanoparticles [ 88 ]. Pre-characterized MSNs with pre-specified aerodynamic diameters were initially assessed through scanning mobility particle sizing to yield accurate size-distribution inputs. Asymmetric mouse airway geometry and physiological parameters such as respiratory rate, lung volume, and airflow were used in simulations that were approximated to provide a total lung deposition of about 45%, of which 37% was in the head, 27% in the tracheobronchial, and 36% in the pulmonary (alveolar) region. These predictions are in reasonable agreement with earlier in vivo findings, validating the model. MPPD analysis also indicated that smaller MSNs exhibit more alveolar deposition, with the larger particles being better in the upper airways. Through linking aerosolization efficiency (via size distribution and concentration) and regional deposition, this modeling approach orients optimization of nanoparticle size and generation techniques toward maximizing targeted lung delivery [ 88 ]. To achieve easier production of aerosols, the surface of nanoparticles is often provided with a polymer coating, thereby stabilizing their distribution and increasing dispersibility [ 56 ]. By lowering the particle size, deeper lung areas can be reached [ 25 ]. Particles smaller than 1 µm are capable of accumulating in the alveoli, but the ideal size range to achieve maximum efficiency is in the 200-500 nm range [ 25 ]. Nevertheless, another review cited that particle size in the range of 50-200 nm is ideal for maximizing drug localization by inhalation [ 89 ]. It has also been recommended that the perfect diameter is approximately 500 nm for phagocytosis by alveolar macrophages [ 89 ]. Li et al. nebulized PEI-PEG-coated MSNs (50 nm particle size) by standard nebulizers without compromising their structure, while keeping particles in their individual form within the water droplets [ 90 ]. The aerosol supplies convenient delivery of MSNs to all areas of the respiratory tract - nasal, tracheobronchial, and pulmonary - and they persist for a week following inhalation, mostly within alveolar macrophages. It offers intracellular targeted delivery of lung diseases without passing through the gastrointestinal and first-pass metabolism. In spite of decreased deep lung deposition in mice under nasal breathing, exposure is comparable to that of humans with inhalation. Toxicity tests revealed no tissue damage or inflammation, further supporting MSN inhalation as a safe and effective method for vast treatment of pulmonary diseases, feasible for clinical translation [ 90 ]. A study investigated the effect of surface chemistry on drug loading capacity, release kinetics, and antibiotic activity in pulmonary infections on S. aureus bacterial cultures [ 18 ]. The model drugs were isoniazid, rifampicin, and vancomycin. Remarkable absorption ability was observed only with thiol (-SH) grafted carriers for all the tested drugs [ 18 ]. The in vitro drug release study showed sustained, but limited release: the cumulative release of rifampicin was 78.5% after 12 days, estimated by antibiogram [ 18 ]. Interestingly, the MIC values of the MSN-drug complex were higher for the free drug, probably due to the delayed and incomplete release from the pores [ 18 ]. Wang et al. developed a polydopamine-coated MSN formulation co-loaded with Ziyuglycoside I and Oseltamivir for the treatment of viral pneumonia. Interestingly, in vitro and in vivo studies have demonstrated that this carrier provided immediate release of Oseltamivir (allows quick virus killing) but prolonged release of Ziyuglycoside I (cuts down the inflammatory response for a longer period) [ 62 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.